Helicobacter pylori infection is the primary cause of gastric cancer

Journal of Gastroenterology

Volumn 35, Issue SUPPL. 12, 2000, Pages 90-97

  Graham, David Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Causation; Epidemiology; Gastric cancer; Gastritis; Helicobacter pylori; Odds ratio

Indexed keywords

AGE; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER RISK; CONFERENCE PAPER; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; STOMACH CANCER;

CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0034063957     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 61: Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: International Agency for Research on Cancer, 1994.
2. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975;2:58-60.
3. Haenszel W, Correa P. Developments in the epidemiology of stomach cancer over the past decade. Cancer Res 1975;35:3452-9.
4. Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976;57:1027-35.
5. Cuello C, Correa P, Haenszel W, Gordillo G, Brown C, Archer M, et al. Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst 1976;57:1015-20.
6. Haenszel W, Correa P, Cuello C, Guzman N, Burbano LC, Lores H, et al. Gastric cancer in Colombia. II. Case-control epidemiologic study of precursor lesions. J Natl Cancer Inst 1976;57: 1021-6.
7. Graham DY, Klein PD, Evans DG, Fiedorek SC, Evans DJ Jr, Adam E, et al. Helicobacter pylori: epidemiology, relationship to gastric cancer and the role of infants in transmission. Eur J Gastroenterol Hepatol 1992;4(Suppl 1):S1-6.
8. Silverstein AM. A history of immunology. San Diego: Academic, 1989.
9. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States: effect of age, race, and socioeconomic status. Gastroenterology 1991;100:1495-501.
10. Graham DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991;6:105-13.
11. Graham DY, Adam E, Klein PD, Evans DJ Jr, Evans DG, Hazell SL, et al. Epidemiology of Campylobacter pylori infection. Gastroenterol Clin Biol 1989;13:84B-8B.
12. Breuer T, Malaty HM, Graham DY. The epidemiology of H. pylori-associated gastroduodenal diseases. In: Ernst P, Michetti P, Smith PD, editors. The immunobiology of H. pylori from pathogenesis to prevention. Philadelphia: Lippincott-Raven; 1997. p. 1-14.
13. Evans AS, Mueller NE. Viruses and cancer: causal associations. Ann Epidemiol 1990;1:71-92.
14. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
15. Correa P, Fox J, Fontham E, Ruiz B, Lin YP, Zavala D, et al. Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66:2569-74.
16. Tsugane S, Kabuto M, Imai H, Gey F, Tei Y, Hanaoka T, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993;4:297-305.
17. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997;113:1983-91.
18. Fukao A, Komatsu S, Tsubono Y, Hisamichi S, Ohori H, Kizawa T, et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes Control 1993;4:307-12.
19. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-5.
20. Nomura A, Stemmermann GN. Helicobacter pylori and gastric cancer. J Gastroenterol Hepatol 1993;8:294-303.
21. Kim HY, Cho BD, Chang WK, Kim DJ, Kim YB, Park CK, et al. Helicobacter pylori infection and the risk of gastric cancer among the Korean population. J Gastroenterol Hepatol 1997;12:100-3.
22. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
23. Nomura A, Stemmermann GN, Chyou PH, Kalo I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325:1132-6.
24. Huang JQ, Sridhar S, Chen Y, Hunt RH, Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-79.
25. Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999;13:851-6.
26. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102:760-6.
27. Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994;73:2691-4.
28. Graham DY, Go MF, Genta RM. Helicobacter pylori, duodenal ulcer, gastric cancer: tunnel vision or blinders? Ann Med 1995;27: 589-94.
29. Kituchi S, Wada O, Nakajima T, Kobayashi O, Yamazaki T, Kikuichi M, et al. Asssociation between gastric cancer and H. pylori wiht reference to age (abstract). Gut 1995;37(Suppl 1): A8.
30. Correa P, Haenszel W, Tannenbaum S. Epidemiology of gastric carcinoma: review and future prospects. Natl Cancer Inst Monogr 1982;62:129-34.
31. Graham DY, Yamaoka Y. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 1998;3:145-51.
32. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 1998;3:241-53.
33. Perez-Perez GI, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, et al. Country-specific constancy by age in cagA proportion of Helicobacter pylori infections. Int J Cancer 1997;72:453-6.
34. Faber K. Chronic gastritis: its relation to achylia and ulcer. Lancet 1927;2:902-7.
35. Faber K. Gastritis and its consequences. Paris: Oxford University Press, 1935.
36. Dixon MF. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol 1991;6:125-30.
37. Ota H, Genta RM. Morphological characterization of the gastric mucosa during infection with H. pylori. In: Ernst P, Michetti P, Smith PD, editors. The immunobiology of H. pylori from pathogenesis to prevention. Philadelphia: Lippincott-Raven; 1997. p. 15-28.
38. Tarpila S, Kekki M, Samloff IM, Sipponen P, Siurala M. Morphology and dynamics of the gastric mucosa in duodenal ulcer patients and their first-degree relatives. Hepatogastroenterology 1983;30: 198-201.
39. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615-25.
40. Kekki M, Saukkonen M, Sipponen P, Varis K, Siurala M. Dynamics of chronic gastritis in the remnant after partial gastrectomy for duodenal ulcer. Scand J Gastroenterol 1980;15:509-12.
41. Meining A, Kiel G, Stolte M. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus under 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease (abstract). Gastroenterology 1998;114: A224.
42. Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM, Appelmelk BJ, Schenk BE, Meuwissen SG. Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl 1997;223:28-34.
43. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
44. Chang HC. Gastric secretion in fever and infectious diseases. J Clin Invest 1933;12:155-69.
45. Faber K, Gastritis and its consequences. Paris: Oxford University Press, 1935.
46. Nyfeldt A, Vimtrup B. Gastritis acuta bei Diphtheria faucium. Acta Med Scand 1932;78:447-83.
47. Levenstein H. Revolution at the table: the transformation of the American diet. London; Oxford University Press; 1988.
48. Buiatti E, Munoz N. Chemoprevention of stomach cancer. IARC Sci Publ 1996;35-9.
49. Nomura A, Yamakawa H, Ishidate T, Kamiyama S, Masuda H, Stemmermann GN, et al. Intestinal metaplasia in Japan: association with diet. J Natl Cancer Inst 1982;68:401-5.
50. Hirohata T, Kono S, Diet/nutrition and stomach cancer in Japan. Int J Cancer 1997;(Suppl 10):34-6.
51. Goodman KJ, Correa P, Tengana Aux HJ, DeLany JP, Collazos T. Nutritional factors and Helicobacter pylori infection in Colombian children. J Pediatr Gastroenterol Nutr 1997;25:507-15.
52. Fay M, Fennerty MB, Emerson J, Larez M. Dietary habits and the risk of stomach cancer: a comparison study of patients with and without intestinal metaplasia. Gastroenterol Nurs 1994;16:158-62.
53. Correa P, Malcom G, Schmidt B, Fontham E, Ruiz B, Bravo JC, et al. Review article: antioxidant micronutrients and gastric cancer. Aliment Pharmacol Ther 1998;12(Suppl 1):73-82.
54. Correa P. The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. Front Gastrointest Res 1980;6:98-108.
55. Lee JK, Park BJ, Yoo KY, Ahn YO. Dietary factors and stomach cancer: a case-control study in Korea. Int J Epidemiol 1995;24: 33-41.
56. Correa P, Fontham E, Pickle LW, Chen V, Lin YP, Haenszel W. Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst 1985;75:645-54.
57. Breidenback AW, Kay FE. Gastric ascorbic acid in the gastritic guinea pig. Science 1953;118:557.
58. Freeman JT, Hafkesbring R. Comparative studies of ascorbic acid levels in gastric secretion and blood. III. Gastrointestinal diseases. Gastroenterology 1957;32:878-86.
59. Haenszel W, Cuello C, Correa P, Lopez A, Zarama G, Zavala D. Correlations of values of micronutrients in sera with gastric pathology. Natl Cancer Inst Monogr 1985;69:115-9.
60. Banergee S, Hawksby K, Miller S, Beattie AD, McColl KEL. Effect of H. pylori and its eradication on gastric juice ascorbic acid. Gut 1994;35:317-22.
61. Sobala GM, Schorah CJ, Shires S, Lynch DA, Gallacher B, Dixon MF, et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993;34:1038-41.
62. Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KE. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994;35:317-22.
63. Ruiz B, Correa P, Fontham ET, Rood JC, Malcom GT, Torrado J, et al. Ascorbic acid. Helicobacter pylori and Lewis phenotype among blacks and whites in New Orleans. Cancer Lett 1994;83: 323-9.
64. Ruiz B, Rood JC, Fontham ET, Malcom GT, Hunter FM, Sobhan M, et al. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994;89: 533-9.
65. Correa P, Fontham ET, Ruiz B, Malcom GR, Hunter FM, Zavala DE. Gastric juice ascorbic acid after intravenous injection: effect of ethnicity, pH, and Helicobacter pylori infection. J Natl Cancer Inst 1995;87:52-3.
66. Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels: impact of eradication. Dig Dis Sci 1995;40:615-21.
67. Waring AJ, Drake IM, Schorah CJ, White KL, Lynch DA, Axon AT, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996;38:171-6.
68. Zhang ZW, Patchett SE, Perrett D, Katelaris PH, Domizio P, Farthing MJ. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut 1998;43:322-6.
69. Zhang HM, Wakisaka N, Maeda O, Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer 1997;80:1897-903.
70. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996;56:3238-43.
71. Everett SM, White K, Drake I, Schorah C, Axon A. H. pylori is associated with reduced plasma ascorbic acid concentration (abstract). Gastroenterology 1999;116:A399.
72. Reed PI. The ECP-IM intervention study. Eur J Cancer Prev 1994;3(Suppl 2):99-104.
73. MacGregor GA, de Wardener HE, Salt, diet & health. Cambridge: Cambridge University Press, 1998.
74. Tsugane S, Akabane M, Inami T, Matsushima S, Ishibashi T, Ichinowatari Y, et al. Urinary salt excretion and stomach cancer mortality among four Japanese populations. Cancer Causes Control 1991;2:165-8.
75. Kumagai T, Malaty HM, Graham DY, Hosogaya S, Misawa K. Furihata K, et al. Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis 1998;178:717-21.
76. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997;32:664-8.
77. Bockus HL. Carcinoma of the stomach. In: Bockus HL, editor. Gastroenterology. 2nd ed. Philadelphia: Saunders; 1963, p. 743-801.
78. Graham DY. Helicobacter pylori, GERD, NSAIDs, and cancer: where we really stand (letter). Am J Gastroenterol 1999;94: 1420-1.
79. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642-8.
80. Solcia E, Rindi G, Fiocca R, Villani L, Buffa R, Ambrosiani L, et al. Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med 1992;65:793-804.
81. Annibale B, Marignani M, Azzoni C, D'Ambra G, Caruana P, D'Adda T, et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997; 2:57-64.
82. Graham DY. Can therapy ever be denied for Helicobacter pylori infection? (editorial). Gastroenterology 1997;113:S113-7.